Invesco Ltd. Astrazeneca PLC Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Invesco Ltd. holds 2,937,049 shares of AZN stock, worth $186 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,937,049

Previous 3,217,123 8.71%

Holding current value

$186 Million

Previous $251 Million 8.79%

% of portfolio

0.05%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $21.5 Million - $24.5 Million	-280,074 Reduced 8.71%	2,937,049 $229 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $20 Million - $24.1 Million	298,743 Added 10.24%	3,217,123 $251 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $22.8 Million - $25.9 Million	-372,879 Reduced 11.33%	2,918,380 $198 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $98.3 Million - $110 Million	-1,587,975 Reduced 32.55%	3,291,259 $222 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $57.2 Million - $63.3 Million	-882,653 Reduced 15.32%	4,879,234 $330 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $81.8 Million - $88.7 Million	-1,169,597 Reduced 16.87%	5,761,887 $412 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $56.7 Million - $64.3 Million	898,181 Added 14.89%	6,931,484 $481 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $26.2 Million - $34 Million	-483,293 Reduced 7.42%	6,033,303 $409 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $15.9 Million - $40.6 Million	299,442 Added 4.82%	6,516,596 $357 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $58.7 Million - $70.4 Million	-989,980 Reduced 13.74%	6,217,154 $411 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $13.2 Million - $16 Million	237,697 Added 3.41%	7,207,134 $478 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $41.6 Million - $49.1 Million	-769,272 Reduced 9.94%	6,969,437 $406 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $103 Million - $113 Million	-1,853,639 Reduced 19.32%	7,738,709 $465 Million
Q2 2021 Aug 17, 2021	SELL	$48.42 - $60.18 $962,250 - $1.2 Million	-19,873 Reduced 0.21%	9,592,348 $575 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $21.8 Million - $25.2 Million	462,940 Added 5.06%	9,612,221 $478 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $6 Million - $7.17 Million	-123,637 Reduced 1.33%	9,149,281 $457 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $50.3 Million - $58 Million	-948,469 Reduced 9.28%	9,272,918 $508 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $26.1 Million - $33.4 Million	-604,621 Reduced 5.58%	10,221,387 $541 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $79.6 Million - $108 Million	2,106,066 Added 24.15%	10,826,008 $483 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $1.75 Million - $2.08 Million	-41,282 Reduced 0.47%	8,719,942 $435 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $138 Million - $157 Million	3,452,043 Added 65.02%	8,761,224 $390 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $135 Million - $151 Million	3,617,993 Added 213.93%	5,309,181 $219 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $393,193 - $476,618	-11,079 Reduced 0.65%	1,691,188 $68.4 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $62.7 Million - $70.6 Million	1,702,267 New	1,702,267 $64.7 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account